DeepMed Research

UNIVERSITY COLLEGE LONDON

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private

Established: 1826-02-11

Employees: 10K

Market Cap: -

Website: http://www.ucl.ac.uk

Clinical Trials

Anosmia and Covid-19

Not Applicable

Completed

Conditions: Anosmia
SARS CoV 2 Infection

Interventions: Other: Olfactory Training

First Posted Date: 2022-02-18

Last Posted Date: 2022-02-18

Lead Sponsor: University College, London

Target Recruit Count: 63

Registration Number: NCT05246059

Locations: 🇬🇧
James Paget and Norfolk & Norwich University Hospitals, Gorleston-on-Sea, Great Yarmouth, United Kingdom
🇬🇧
Wrightington, Wigan and Leigh NHS Foundation Trust, Wigan, England, United Kingdom
🇬🇧
Barts Health NHS Foundation Trust, London, England, United Kingdom

and more 1 locations

The Effect of Exercise in Patients Awaiting Bariatric Surgery

Not Applicable

Recruiting

Conditions: Obesity
Bariatric Surgery Candidate

Interventions: Behavioral: Online exercise intervention

First Posted Date: 2022-02-11

Last Posted Date: 2025-05-21

Lead Sponsor: University College, London

Target Recruit Count: 48

Registration Number: NCT05235945

Locations: 🇬🇧
University College London, London, United Kingdom

NEOadjuvant PembRolizumab In Stratified Medicine - ColoRectal Cancer

Phase 2

Recruiting

Conditions: Adenocarcinoma of the Colon

Interventions: Drug: Pembrolizumab

First Posted Date: 2022-01-19

Last Posted Date: 2024-08-05

Lead Sponsor: University College, London

Target Recruit Count: 78

Registration Number: NCT05197322

Locations: 🇬🇧
Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom
🇬🇧
St James University Hospital (SJUH), Leeds, United Kingdom
🇬🇧
Southampton General Hospital, Southampton, United Kingdom

and more 2 locations

Perioperative Pembrolizumab and Lenvatinib in Resectable Hepatocellular Carcinoma (HCC)

Phase 2

Recruiting

Conditions: Hepatocellular Carcinoma

Interventions: Drug: Lenvatinib
Drug: Pembrolizumab and Lenvatinib
Drug: Pembrolizumab

First Posted Date: 2022-01-11

Last Posted Date: 2024-12-06

Lead Sponsor: University College, London

Target Recruit Count: 60

Registration Number: NCT05185739

Locations: 🇬🇧
Freeman Hospital, Newcastle Upon Tyne, United Kingdom
🇬🇧
Queen Elizabeth Hospital, Birmingham, United Kingdom
🇬🇧
Addenbrooke's Hospital, Cambridge, United Kingdom

and more 8 locations

Mechanisms of Acute Inflammation Following Periodontal Treatment

Not Applicable

Not yet recruiting

Conditions: Inflammation
Periodontal Diseases

Interventions: Procedure: IPT+PDT
Procedure: IPT+Placebo

First Posted Date: 2022-01-05

Last Posted Date: 2023-11-29

Lead Sponsor: University College, London

Target Recruit Count: 40

Registration Number: NCT05178563

Locations: 🇬🇧
Eastman Dental Hospital, London, United Kingdom

Defining Robust Predictors of Chemotherapy Related Cardiotoxicity

Recruiting

Conditions: Gastrointestinal Neoplasms
Cardiotoxicity

First Posted Date: 2021-12-16

Last Posted Date: 2023-09-21

Lead Sponsor: University College, London

Target Recruit Count: 600

Registration Number: NCT05159479

Locations: 🇬🇧
St Bartholomews Hospital, London, United Kingdom

Long-Acting Treatment in Adolescents (LATA)

Phase 3

Active, not recruiting

Conditions: Hiv
HIV Infections
HIV-1-infection
Paediatric Human Immunodeficiency Virus Infection

Interventions: Drug: Cabotegravir, Rilpivirine Drug Combination
Drug: TLD

First Posted Date: 2021-12-13

Last Posted Date: 2024-04-29

Lead Sponsor: University College, London

Target Recruit Count: 476

Registration Number: NCT05154747

Locations: 🇺🇬
Baylor College of Medicine Childrens Foundation Uganda, Kampala, Uganda
🇺🇬
Joint Clinical Research Centre, Kampala, Uganda
🇿🇦
Enhancing Care Foundation King Edward VIII Hospital, Durban, South Africa

and more 2 locations

The Baby Lung Study

Completed

Conditions: Neonatal Disease
Bronchopulmonary Dysplasia

First Posted Date: 2021-12-09

Last Posted Date: 2023-11-29

Lead Sponsor: University College, London

Target Recruit Count: 61

Registration Number: NCT05152316

Locations: 🇬🇧
University College London Hospital, London, United Kingdom

Point of Care RandOmisation Systems for Performing Embedded Comparative Effectiveness Trials Of Routine Treatments

Phase 4

Recruiting

Conditions: Atrial Fibrillation New Onset
Magnesium Deficiency

Interventions: Other: Electronic Point of Care Randomisation tool
Drug: Magnesium

First Posted Date: 2021-12-08

Last Posted Date: 2022-11-01

Lead Sponsor: University College, London

Target Recruit Count: 100

Registration Number: NCT05149820

Locations: 🇬🇧
University College London Hospitals NHS Trust, London, United Kingdom

Evaluating the NeoTree in Malawi and Zimbabwe

Conditions: Prematurity
Neonatal Sepsis
Neonatal Seizure
Neonatal Hypothermia
Neonatal Respiratory Failure
Neonatal Encephalopathy
Neonatal Hypoglycemia
Neonatal Death
Neonatal Jaundice
Neonatal Disorder

Interventions: Device: Neotree

First Posted Date: 2021-11-19

Last Posted Date: 2022-05-18

Lead Sponsor: University College, London

Target Recruit Count: 19000

Registration Number: NCT05127070

Locations: 🇲🇼
Kamuzu Central Hospital, Lilongwe, Malawi
🇿🇼
Chinhoyi Provincial Hospital, Chinhoyi, Zimbabwe
🇿🇼
Bindura Provincial Hospital, Bindura, Zimbabwe

and more 2 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy